Corporate News 17-Mar-23
Punjab & Sind Bank revises MCLRs
With effect from 16 March 2023
Punjab & Sind Bank has revised the Marginal Cost of Funds based Lending Rates (MCLR) across different tenures with effect from 16 March 2023 as under:
Overnight - 7.70%
One month - 7.80%
Three month - 8.30%
Six month - 8.45%
One year - 8.60%
Previous News
Punjab & Sind Bank standalone net profit declines 69.51% in the March 2024 quarter
( Results - Announcements 11-May-24 07:35 )
Broader market outperforms; PSU bank shares in demand
( Market Commentary - Mid-Session 29-Jul-24 10:34 )
Punjab & Sind Bank revises MCLRs
( Corporate News - 15-Jan-24 15:14 )
Punjab & Sind Bank spurts 3.66%, up for five straight sessions
( Hot Pursuit - 18-May-24 13:00 )
Board of Punjab & Sind Bank recommends final dividend
( Corporate News - 11-May-24 09:41 )
Punjab & Sind Bank spurts 4.72%, gains for third straight session
( Hot Pursuit - 18-Jul-24 13:05 )
Punjab & Sind Bank down for fifth straight session
( Hot Pursuit - 07-May-24 13:35 )
Punjab & Sind Bank announces board meeting date
( Corporate News - 26-Jul-22 10:41 )
Punjab & Sind Bank Q4 PAT rises 32% YoY to Rs 457 cr
( Hot Pursuit - 03-May-23 10:56 )
Punjab & Sind Bank up for third straight session
( Hot Pursuit - 13-Nov-23 13:05 )
Punjab & Sind Bank reports standalone net profit of Rs 173.85 crore in the June 2021 quarter
( Results - Announcements 29-Jul-21 16:05 )
Other Stories
Anmol India to conduct board meeting
03-Oct-24 10:07
KPI Green Energy receives CEIG approval for 5 MW solar power project
03-Oct-24 10:04
Navkar Corporation revises board meeting date
03-Oct-24 09:52
Paytm deploys card machines across 2 Krishi Mandis in Madhya Pradesh
03-Oct-24 09:52
Adani Ports records 14% growth in cargo volumes in September 2024
03-Oct-24 09:37
SignatureGlobal India launches new project in Gurugram
03-Oct-24 09:34
Biocon Biologics refinances debt through USD bonds and syndicated term loan
03-Oct-24 09:29
RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
03-Oct-24 09:26
Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
03-Oct-24 09:23
Transformers & Rectifiers India wins order of Rs 565 cr
03-Oct-24 09:07
Back
Top
